Revenue
2018
2019
2020
2021
2022
2023
2024
2025
BIO-TECHNE Corp (TECH)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.22B | $1.16B | $1.14B | $1.11B | $931.0M | $738.7M | $714.0M | $643.0M | $563.0M | $499.0M | $452.2M | $357.8M | $310.6M | $314.6M | $290.0M | $269.0M | $264.0M |
| Gross profit | $790.3M | $769.7M | $769.8M | $756.5M | $632.9M | $483.2M | $473.5M | $432.1M | $374.5M | $336.7M | $307.3M | $251.4M | $231.1M | $235.8M | $224.9M | $214.1M | $208.0M |
| Research & development | $99.5M | $96.7M | $92.5M | $87.1M | $70.6M | $65.2M | $62.4M | $55.3M | $53.5M | $45.2M | $40.9M | $30.9M | $29.3M | $27.9M | $26.0M | $25.1M | $23.6M |
| Operating expenses | $688.0M | $563.0M | $470.9M | $459.9M | $395.6M | $325.8M | $326.8M | $296.0M | $254.0M | $186.1M | $160.3M | $91.7M | $72.6M | $69.6M | $61.9M | $57.8M | $57.3M |
| Operating income | $102.3M | $206.7M | $298.9M | $296.6M | $237.3M | $157.4M | $146.7M | $136.2M | $120.6M | $150.6M | $147.0M | $159.8M | $158.5M | $166.2M | $163.1M | $156.3M | $150.8M |
| EBITDAderived | $212.2M | $318.4M | $406.2M | $397.7M | $325.0M | $240.2M | $224.9M | $200.6M | $180.6M | $193.4M | $184.2M | $178.9M | $170.8M | $178.7M | $171.8M | $164.5M | $158.5M |
| Net income | $73.4M | $168.1M | $285.3M | $272.1M | $140.4M | $229.3M | $96.1M | $126.2M | $76.1M | $104.5M | $107.7M | $110.9M | $112.6M | $112.3M | $112.3M | $109.8M | $105.2M |
| Basic EPSper diluted share | $0.47 | $1.07 | $1.81 | $1.73 | $0.91 | $6.00 | $2.54 | $3.36 | $2.04 | $2.81 | $2.90 | $3.01 | $3.06 | $3.04 | $3.03 | $2.95 | $2.78 |
| Diluted EPSper diluted share | $0.46 | $1.05 | $1.76 | $1.66 | $0.87 | $5.82 | $2.47 | $3.31 | $2.03 | $2.80 | $2.89 | $3.00 | $3.05 | $3.04 | $3.02 | $2.94 | $2.78 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 8, 2026Form 4 | Herr Amy E.Director | SellCommon Stock · indirect | 6.6K | $48.28 | $320.4K | 200 |
| Feb 17, 2026Form 4 | Herr Amy E.Director | SellCommon Stock · indirect | 2.0K | $59.11 | $116.8K | 200 |
| Aug 25, 2025Form 4 | Nusse RoelandDirector | SellCommon Stock | 17.0K | $56.36 | $960.4K | 44.6K |
| Aug 25, 2025Form 4 | BAUMGARTNER ROBERT VDirector | SellCommon Stock | 17.0K | $56.21 | $957.8K | 44.9K |
| Jun 9, 2025Form 4 | Herr Amy E.Director | SellCommon Stock · indirect | 1.3K | $49.77 | $63.7K | 2.0K |